McKesson's most recent trend suggests a bullish bias. One trading opportunity on McKesson is a Bull Put Spread using a strike $155.00 short put and a strike $145.00 long put offers a potential 11.73% return on risk over the next 32 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $155.00 by expiration. The full premium credit of $1.05 would be kept by the premium seller. The risk of $8.95 would be incurred if the stock dropped below the $145.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for McKesson is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for McKesson is bullish.
The RSI indicator is at 60.72 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for McKesson
U.S. Senate backs bill to regulate big drug compounders
Mon, 18 Nov 2013 19:55:40 GMT
Reuters – The U.S. Senate on Monday approved a bill designed to prevent the type of quality control problems that lead last year to a deadly outbreak of fungal meningitis that was traced to a tainted pharmaceutical mixed by a Massachusetts pharmacy. The bill, known as the Drug Quality and Security Act, will give the Food and Drug Administration greater authority to regulate companies that compound sterile drugs and ship them across state lines. The bill was passed earlier by the House of Representatives and is expected to be signed into law by President Barack Obama within days. The legislation draws a distinction between traditional compounding pharmacies, which will continue to be regulated by state boards of pharmacy, and large-scale compounding pharmacies such as the New England Compounding Center in Framingham, Massachusetts, which was at the heart of the meningitis outbreak that killed more than 50 people.
Singer Builds Celesio Stake as McKesson Plans Acquisition
Thu, 14 Nov 2013 15:42:51 GMT
MCK January 2016 Options Begin Trading
Wed, 13 Nov 2013 15:44:00 GMT
Symantec falls as another top executive to leave
Tue, 12 Nov 2013 18:20:00 GMT
AP – Shares of Symantec fell Tuesday after the security software maker said that its president of products and services is leaving next month. Symantec Corp. said late Monday that Francis deSouza will depart …
MCKESSON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Tue, 12 Nov 2013 13:31:30 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook